ArticleHeart rhythm O22025
Rising burden of cancer and atrial fibrillation-related mortality among adults in the United States, 1999-2019.
Article in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends and Disparities in Cancer-Related Mortality Among Adults With Diabetes in the United States: 1999-2019.Endocrinology, diabetes & metabolism · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia, whereas cancer remains the second leading cause of death in the United States. Both conditions share several risk factors and may compound mortality risk. However, national trends in AF and cancer-related mortality remain underexplored. Objective: To assess trends in mortality related to AF and cancer among US adults from 1999 to 2019, using demographic and geographic stratifications. Methods: Data were obtained from the CDC WONDER Multiple Cause of Death data set. We identified individuals aged 25 years and older with AF (I48) and cancer (C00-C97) as an underlying or contributing cause of death. Age-adjusted mortality rates (AAMRs) per 100,000 population, average annual percentage change, and annual percentage change were calculated. Results: The AAMR for cancer and AF-related deaths increased from 4.95 (95% confidence interval [CI]: 4.84, 5.05) in 1999 to 10.01 (95% CI: 9.88, 10.13) in 2019 (average annual percentage change: 3.49 [95% CI: 3.39, 3.60]). Males had higher AAMRs than females (10.24 vs 5.13). Non-Hispanic Whites had the highest AAMRs (7.89), followed by non-Hispanic Blacks (4.53) and Hispanics (3.11). The Western region had the highest AAMR, and nonmetropolitan areas exhibited greater mortality rates than metropolitan areas. Individuals with lung cancer exhibited the highest AAMRs (1.65), followed by gastrointestinal cancer (1.52) and hematologic cancer (1.00). The lowest AAMRs were observed in prostate cancer (0.90) and breast cancer (0.65). Conclusion: Mortality from cancer and AF has increased over time, with significant disparities across sex, race, and geography. Targeted interventions are required to mitigate these disparities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.